Working… Menu

Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19 (OsCOVID19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04386447
Recruitment Status : Withdrawn (The study was not approved by the Italian Medicines Agency (AIFA).)
First Posted : May 13, 2020
Last Update Posted : January 14, 2021
University of Parma
Information provided by (Responsible Party):
Tiziana Meschi, Azienda Ospedaliero-Universitaria di Parma

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : October 31, 2020
Estimated Study Completion Date : December 31, 2020